December 22, 2025
The U.S. behavioral health market is projected to expand from USD 101.84 billion in 2026 to USD 159.35 billion...
Read MoreDecember 24, 2025
The smart healthcare market is expected to rise from USD 397.98 billion in 2026 to USD 1833.7 billion by 2035,...
Read MoreJanuary 21, 2026
The medical device CMO and CDMO market is expected to see growth from USD 52.57 billion in 2026 to USD 110.82 ...
Read MoreDecember 29, 2025
The cardiometabolic diseases market size is anticipated to grow from USD 292.04 billion in 2026 to USD 1987.69...
Read MoreNovember 01, 2025
Market insights predict, the compound management industry is expected to grow from USD 492.14 million in 2024 to USD 1899.41 million by 2034, driven by a CAGR of 14.51%. The compound management market is expanding due to growing outsourcing trends, as well as increasing clinical trials. North America led the market due to the presence of huge...
November 01, 2025
Based on market forecasts, the U.S. Controlled Substance market, projected at USD 52.3 billion in 2024, is expected to reach USD 84.95 billion by 2034, growing at a CAGR of 5.24% over the forecast period. The U.S. Controlled Substance Market is growing because these substances extend throughout manufacture, use, handling, distribution, and storage....
November 01, 2025
According to market projections, the global albumin pharma market, valued at USD 6.77 billion in 2024, is anticipated to reach USD 11.72 billion by 2034, growing at a CAGR of 5.65% over the next decade. The rising prevalence of chronic diseases such as liver cirrhosis, kidney disorders, and cardiovascular conditions increases demand for albumin-bas...
November 01, 2025
Projections indicate that, the global pharmaceutical stability & storage services market will increase from USD 3.4 billion in 2024 to USD 5.92 billion by 2034, experiencing a CAGR of 5.7% over the next 10 years. The compliance with global standards and the effectiveness of scientific quality assurance raise the importance of pharmaceuticals. N...
November 01, 2025
According to market projections, the oncology drugs sector is expected to grow from USD 204.39 billion in 2024 to USD 360.79 billion by 2034, reflecting a CAGR of 6.29%. The oncology drugs market is growing due to the increasing incidence of cancer, as poor lifestyle, longer working period, progressively stressful lives, alcohol consumption, smokin...
November 01, 2025
According to market projections, the U.S. pain management drugs sector is expected to grow from USD 31.84 billion in 2024 to USD 44.92 billion by 2034, reflecting a CAGR of 3.64%. The U.S. pain management drugs market is growing due to rising cases of surgeries....
November 01, 2025
The HIV PrEP market is expanding due to its growing approvals as well as rising long-acting injectable PrEP innovations. North America led the market due to the early adoption of the HIV PrEP....
November 01, 2025
Market insights predict, the U.S. pharmaceutical water industry is expected to grow from USD 7.11 billion in 2024 to USD 17.04 billion by 2034, driven by a CAGR of 8.94%. Rising demand for injectable drugs, vaccines, biologics, and biosimilars, which require ultra-pure water like Water for Injection(WFI), has driven the growth of the market....
October 30, 2025
According to market projections, the global antipyretic and analgesic drugs market, valued at USD 47.47 billion in 2024, is anticipated to reach USD 77.99 billion by 2034, growing at a CAGR of 5.09% over the next decade. The rising prevalence of fever, headache, muscle pain, and inflammation-related conditions has driven the growth of the market. N...
October 29, 2025
Projections indicate that, the global injection flu shot market will increase from USD 10.63 billion in 2024 to USD 29.97 billion by 2034, experiencing a CAGR of 10.93% over the next 10 years. The increasing number of elderly individuals, who are more susceptible to serve flu complications, has heightened the demand for the flu vaccines. North Amer...
+1 804 441 9344
+61 4859 81310 or +91 87933 22019
sales@towardshealthcare.com